Fludroxycortide cream as an alternative therapy for actinic cheilitis.

Objectives: The objective of the study is to assess, by clinical follow-up, the efficacy of the dermatological cream Fludroxycortide 0.125 mg/g (Drenison®) in the treatment of actinic cheilitis (AC).

Material And Methods: Twenty-three patients diagnosed with AC participated in the study.